Otsuka Holdings Co., Ltd. (4578.T)

Tokyo · Healthcare · Drug Manufacturers - General
12,280.00 JPY+0.12%As of 2026-11-12 · JPY
Day low 12,080.00 JPYDay high 12,310.00 JPY
52-week low 8,150.00 JPY52-week high 12,795.00 JPY
Market cap (USD)
$40.22B
Sector
Healthcare
P/E (TTM)
16.7x
Dividend yield
1.66%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-11 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in JPY.

IndicatorValueReading
RSI (14)51.5In the neutral range (30 to 70)
MACD (12, 26, 9)51.52Below its signal line (96.10); histogram -44.58
Bollinger %B (20, 2)62%Inside the bands (11,556.56 to 12,719.94)
SMA 2012,138.25Price is 1.2% above
SMA 5011,812.50Price is 4.0% above
SMA 20011,030.22Price is 11.3% above
ATR (20)3.10% of priceAverage true range per day
52-week position89%In the upper part of the 8,150.00 to 12,795.00 range

About Otsuka Holdings Co., Ltd.

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.

Latest fiscal yearEnded 2025-12-31: revenue of 2.47T JPY and an operating margin of 19.1%.

More in Drug Manufacturers - General